Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 8/2010

01-08-2010 | Original Article

Body Mass Index and Adverse Perioperative Outcomes Following Hepatic Resection

Authors: Amit K. Mathur, Amir A. Ghaferi, Nicholas H. Osborne, Timothy M. Pawlik, Darrell A. Campbell, Michael J. Englesbe, Theodore H. Welling

Published in: Journal of Gastrointestinal Surgery | Issue 8/2010

Login to get access

Abstract

Background

The effect of obesity on perioperative outcomes following hepatic resection is not clearly defined. We sought to understand the implications of obesity on post-hepatectomy outcomes in a nationally represented cohort of patients.

Methods

Using a retrospective cohort design, we studied the effect of obesity on complications and 30-day mortality using multivariable logistic regression using comprehensive clinical data from the American College of Surgeons National Surgical Quality Improvement Program (2005-2008).

Results

During our study period, 3,960 patients underwent hepatic resection; 32.4% had a normal body mass index (BMI; 18.5-24.9 kg/m2), 2.5% were underweight (<18.5 kg/m2), 33.4% were overweight (25.0-29.9 kg/m2), and 31.7% were obese (>30.0 kg/m2). 23.3% had at least one post-operative complication and the overall mortality rate was 2.5%. Compared to normal patients, obese patients had significantly higher unadjusted odds of having a complication (26.5% vs. 21.3%, OR 1.34, 95% CI 1.12-1.61) and dying (3.0% vs. 1.7%, OR 1.79, 95% CI 1.05-3.05). The obese were also more likely to have multiple complications compared to normal BMI patients (6.1% vs. 3.7%, OR 1.70, 95% CI 1.17-2.46). After risk adjustment, obesity was associated with attenuated but significantly higher odds of having any perioperative complication (OR 1.24, 95% CI 1.01-1.55), but was not a significant predictor of mortality.

Conclusions

After adjusting for other clinical factors, the degree of obesity is independently associated with an increasing complication rate but not mortality. Risk adjustment may not capture the total clinical risk of patients at the extremes of BMI.
Literature
1.
go back to reference Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology 2007;132(6):2087–2102.CrossRefPubMed Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology 2007;132(6):2087–2102.CrossRefPubMed
2.
go back to reference Anaya DA, Dellinger EP. The obese surgical patient: a susceptible host for infection. Surg Infect (Larchmt) 2006;7(5):473–480.CrossRef Anaya DA, Dellinger EP. The obese surgical patient: a susceptible host for infection. Surg Infect (Larchmt) 2006;7(5):473–480.CrossRef
3.
go back to reference Doyle SL, Lysaght J, Reynolds JV. Obesity and post-operative complications in patients undergoing non-bariatric surgery. Obes Rev 2009. Doyle SL, Lysaght J, Reynolds JV. Obesity and post-operative complications in patients undergoing non-bariatric surgery. Obes Rev 2009.
4.
go back to reference Mullen JT, Davenport DL, Hutter MM, Hosokawa PW, Henderson WG, Khuri SF et al. Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol 2008;15(8):2164–2172.CrossRefPubMed Mullen JT, Davenport DL, Hutter MM, Hosokawa PW, Henderson WG, Khuri SF et al. Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol 2008;15(8):2164–2172.CrossRefPubMed
5.
go back to reference Pitt HA. Hepato-pancreato-biliary fat: the good, the bad and the ugly. HPB (Oxford) 2007;9(2):92–97. Pitt HA. Hepato-pancreato-biliary fat: the good, the bad and the ugly. HPB (Oxford) 2007;9(2):92–97.
6.
go back to reference Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i–xii, 1-253. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i–xii, 1-253.
7.
go back to reference Merkow RP, Bilimoria KY, McCarter MD, Bentrem DJ. Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg 2009;208(1):53–61.CrossRefPubMed Merkow RP, Bilimoria KY, McCarter MD, Bentrem DJ. Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg 2009;208(1):53–61.CrossRefPubMed
8.
go back to reference Dimick JB, Wainess RM, Cowan JA, Upchurch GR, Jr., Knol JA, Colletti LM. National trends in the use and outcomes of hepatic resection. J Am Coll Surg 2004;199(1):31–38.CrossRefPubMed Dimick JB, Wainess RM, Cowan JA, Upchurch GR, Jr., Knol JA, Colletti LM. National trends in the use and outcomes of hepatic resection. J Am Coll Surg 2004;199(1):31–38.CrossRefPubMed
9.
go back to reference Dimick JB, Cowan JA, Jr., Knol JA, Upchurch GR, Jr. Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg 2003;138(2):185–191.CrossRefPubMed Dimick JB, Cowan JA, Jr., Knol JA, Upchurch GR, Jr. Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg 2003;138(2):185–191.CrossRefPubMed
10.
go back to reference Lyratzopoulos G, Tyrrell C, Smith P, Yelloly J. Recent trends in liver resection surgery activity and population utilization rates in English regions. HPB (Oxford) 2007;9(4):277–280. Lyratzopoulos G, Tyrrell C, Smith P, Yelloly J. Recent trends in liver resection surgery activity and population utilization rates in English regions. HPB (Oxford) 2007;9(4):277–280.
11.
go back to reference Majeed AW, Price C. Resource and manpower calculations for the provision of hepatobiliary surgical services in the UK. Ann R Coll Surg Engl 2004;86(2):91–95.CrossRefPubMed Majeed AW, Price C. Resource and manpower calculations for the provision of hepatobiliary surgical services in the UK. Ann R Coll Surg Engl 2004;86(2):91–95.CrossRefPubMed
12.
go back to reference Vetelainen R, van Vliet A, Gouma DJ, van Gulik TM. Steatosis as a risk factor in liver surgery. Ann Surg 2007;245(1):20–30.CrossRefPubMed Vetelainen R, van Vliet A, Gouma DJ, van Gulik TM. Steatosis as a risk factor in liver surgery. Ann Surg 2007;245(1):20–30.CrossRefPubMed
13.
go back to reference Ryan CK, Johnson LA, Germin BI, Marcos A. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transplant 2002;8(12):1114–1122.CrossRef Ryan CK, Johnson LA, Germin BI, Marcos A. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transplant 2002;8(12):1114–1122.CrossRef
14.
go back to reference Kooby DA, Fong Y, Suriawinata A, Gonen M, Allen PJ, Klimstra DS et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 2003;7(8):1034–1044.CrossRefPubMed Kooby DA, Fong Y, Suriawinata A, Gonen M, Allen PJ, Klimstra DS et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 2003;7(8):1034–1044.CrossRefPubMed
16.
go back to reference Davenport DL, Xenos ES, Hosokawa P, Radford J, Henderson WG, Endean ED. The influence of body mass index obesity status on vascular surgery 30-day morbidity and mortality. J Vasc Surg 2009;49(1):140–147.CrossRefPubMed Davenport DL, Xenos ES, Hosokawa P, Radford J, Henderson WG, Endean ED. The influence of body mass index obesity status on vascular surgery 30-day morbidity and mortality. J Vasc Surg 2009;49(1):140–147.CrossRefPubMed
17.
go back to reference Mathur AK, Ghaferi AA, Sell K, Sonnenday CJ, Englesbe MJ, Welling TH. “Influence of obesity on complications and oncologic outcomes following hepatectomy for malignancy.” J Gastrointest Surg 2010;14(5):849–857. Mathur AK, Ghaferi AA, Sell K, Sonnenday CJ, Englesbe MJ, Welling TH. “Influence of obesity on complications and oncologic outcomes following hepatectomy for malignancy.” J Gastrointest Surg 2010;14(5):849–857.
18.
go back to reference Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Yatabe T, Maeda H et al. Risk factors and predictors for surgical site infection after hepatic resection. J Hosp Infect 2009;73(1):47–53.CrossRefPubMed Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Yatabe T, Maeda H et al. Risk factors and predictors for surgical site infection after hepatic resection. J Hosp Infect 2009;73(1):47–53.CrossRefPubMed
19.
go back to reference Benns M, Woodall C, Scoggins C, McMasters K, Martin R. The impact of obesity on outcomes following pancreatectomy for malignancy. Ann Surg Oncol 2009;16(9):2565–2569.CrossRefPubMed Benns M, Woodall C, Scoggins C, McMasters K, Martin R. The impact of obesity on outcomes following pancreatectomy for malignancy. Ann Surg Oncol 2009;16(9):2565–2569.CrossRefPubMed
20.
go back to reference Gedaly R, McHugh PP, Johnston TD, Jeon H, Ranjan D, Davenport DL. Obesity, diabetes, and smoking are important determinants of resource utilization in liver resection: a multicenter analysis of 1,029 patients. Ann Surg 2009;249(3):414–419.CrossRefPubMed Gedaly R, McHugh PP, Johnston TD, Jeon H, Ranjan D, Davenport DL. Obesity, diabetes, and smoking are important determinants of resource utilization in liver resection: a multicenter analysis of 1,029 patients. Ann Surg 2009;249(3):414–419.CrossRefPubMed
21.
go back to reference House MG, Fong Y, Arnaoutakis DJ, Sharma R, Winston CB, Protic M et al. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg 2008;12(2):270–278.CrossRefPubMed House MG, Fong Y, Arnaoutakis DJ, Sharma R, Winston CB, Protic M et al. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg 2008;12(2):270–278.CrossRefPubMed
22.
go back to reference Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998;2(3):292–298.CrossRefPubMed Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998;2(3):292–298.CrossRefPubMed
23.
go back to reference Gomez D, Malik HZ, Bonney GK, Wong V, Toogood GJ, Lodge JP et al. Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg 2007;94(11):1395–1402.CrossRefPubMed Gomez D, Malik HZ, Bonney GK, Wong V, Toogood GJ, Lodge JP et al. Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg 2007;94(11):1395–1402.CrossRefPubMed
24.
go back to reference El-Badry AM, Breitenstein S, Jochum W, Washington K, Paradis V, Rubbia-Brandt L et al. Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 2009;250(5):691–697.CrossRefPubMed El-Badry AM, Breitenstein S, Jochum W, Washington K, Paradis V, Rubbia-Brandt L et al. Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 2009;250(5):691–697.CrossRefPubMed
25.
go back to reference Pawlik TM, Olino K, Gleisner AL, Torbenson M, Schulick R, Choti MA. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 2007;11(7):860–868.CrossRefPubMed Pawlik TM, Olino K, Gleisner AL, Torbenson M, Schulick R, Choti MA. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 2007;11(7):860–868.CrossRefPubMed
26.
go back to reference Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007;94(3):274–286.CrossRefPubMed Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007;94(3):274–286.CrossRefPubMed
27.
go back to reference Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24(13):2065–2072.CrossRefPubMed Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24(13):2065–2072.CrossRefPubMed
28.
go back to reference Ghaferi AA, Birkmeyer JD, Dimick JB. Complications, failure to rescue, and mortality with major inpatient surgery in medicare patients. Ann Surg 2009;250(6):1029–1034.CrossRefPubMed Ghaferi AA, Birkmeyer JD, Dimick JB. Complications, failure to rescue, and mortality with major inpatient surgery in medicare patients. Ann Surg 2009;250(6):1029–1034.CrossRefPubMed
29.
go back to reference Ghaferi AA, Birkmeyer JD, Dimick JB. Variation in hospital mortality associated with inpatient surgery. N Engl J Med 2009;361(14):1368–1375.CrossRefPubMed Ghaferi AA, Birkmeyer JD, Dimick JB. Variation in hospital mortality associated with inpatient surgery. N Engl J Med 2009;361(14):1368–1375.CrossRefPubMed
Metadata
Title
Body Mass Index and Adverse Perioperative Outcomes Following Hepatic Resection
Authors
Amit K. Mathur
Amir A. Ghaferi
Nicholas H. Osborne
Timothy M. Pawlik
Darrell A. Campbell
Michael J. Englesbe
Theodore H. Welling
Publication date
01-08-2010
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 8/2010
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-010-1232-9

Other articles of this Issue 8/2010

Journal of Gastrointestinal Surgery 8/2010 Go to the issue